Article may be outdated

This article is 6 days old. Some details may have changed since publication.

Nature·3 min read·medium

RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus

D
Drew, Liam
RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus
✦AI Summary

Data from Denmark indicates that a nationwide RSV vaccination program for pregnant people has significantly reduced hospitalizations among infants. The vaccine provides maternal antibodies that protect newborns during their most vulnerable months.

Why it matters

Demonstrates the public health efficacy of maternal immunization strategies in preventing severe respiratory disease in infants.

✦Dive DeeperCreate a free account to unlock

Liam Drew is a freelance science journalist based near London.

Search author on: PubMed Google Scholar

Bluesky Facebook LinkedIn Reddit Whatsapp X Save article View saved research Protection against the respiratory syncytial virus (RSV) must expand to lower-income countries, which are harder hit. Credit: Hailshadow/Getty

“Something’s wrong with the data. There are too few people in hospitals” with respiratory syncytial virus (RSV), epidemiologist Caroline Klint Johannesen recalls a colleague remarking while analysing Danish health records for last winter.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in